End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
149.6 USD | +1.39% |
|
+1.78% | -4.98% |
Jun. 28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
Jun. 28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
Financials (USD)
Sales 2024 * | 88.75B | Sales 2025 * | 92.26B | Capitalization | 352B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.96 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.81 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 131,900 |
Yield 2024 * |
3.3% | Yield 2025 * |
3.45% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.39% | ||
1 week | +1.78% | ||
Current month | +1.89% | ||
1 month | +3.14% | ||
3 months | -6.04% | ||
6 months | -4.98% | ||
Current year | -4.98% |
![Extreme 146.51](/images/extremecours_fleche.png)
![Extreme 144.62](/images/extremecours_fleche.png)
![Extreme 144.2](/images/extremecours_fleche.png)
![Extreme 144.2](/images/extremecours_fleche.png)
![Extreme 140](/images/extremecours_fleche.png)
![Extreme 140](/images/extremecours_fleche.png)
![Extreme 140](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-28 | 149.6 | +1.39% | 6 |
24-06-27 | 147.5 | +0.50% | 1 |
24-06-26 | 146.8 | -1.16% | 4 |
24-06-25 | 148.5 | -0.71% | 5 |
24-06-24 | 149.6 | +1.78% | 5 |
End-of-day quote Kazakhstan S.E., June 27, 2024
More quotes![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+44.05% | 641B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- JNJ Stock
- JNJ_KZ Stock